We are live on ! Find out more
AIM

Alerce Investment Management Portfolio holdings

AUM $56.8M
1-Year Est. Return 31.17%
This Fund
S&P 500
This Quarter Est. Return
+50.19%
1 Year Est. Return
+31.17%
3 Year Est. Return
+25.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$75.2M
AUM Growth
+$16.6M
Cap. Flow
-$1.11M
Cap. Flow %
-1.47%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
ANNX icon
Annexon
ANNX
+$866K

Top Sells

Rank Stock Value
1
ASMB icon
Assembly Biosciences
ASMB
+$1.97M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANNX icon
1
Annexon
ANNX
$834M
$33.6M 44.74%
7,406,024
+350,000
+5% +$866K
AKBA icon
2
Akebia Therapeutics
AKBA
$354M
$20.1M 26.74%
16,205,119
– –
AMWL icon
3
American Well
AMWL
$180M
$15.6M 20.77%
523,786
– –
WHWK
4
Whitehawk Therapeutics
WHWK
$190M
$3.29M 4.38%
1,630,830
– –
RNTX
5
Rein Therapeutics
RNTX
$63.1M
$2.53M 3.37%
830,466
– –
ASMB icon
6
Assembly Biosciences
ASMB
$498M
– –
-185,625
Closed -$1.97M

Similar funds

CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
AFA
Atlas Financial Advisors Oroville, California $64.1M AUM 8.36% 1-Year Est. Return
MCC
Maiden Cove Capital Cape Elizabeth, Maine $65.4M AUM
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return
MC
Meketa Capital Westwood, Massachusetts $44.6M AUM
OAM
Origin Asset Management London, United Kingdom $43.5M AUM 31.63% 1-Year Est. Return
IP
Isomer Partners New York $74.3M AUM 23.95% 1-Year Est. Return
JCP
Jennifer C. Price $75.5M AUM 6.25% 1-Year Est. Return

Alerce Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, Alerce Investment Management held 6 positions worth $75.2M, up 28% from $58.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Alerce Investment Management's Q4 2023 filing shows 1 increased and 1 closed positions. The largest sale was Assembly Biosciences, an estimated $1.97M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Alerce Investment Management added most to Annexon in Q4 2023, an estimated $866K increase.
  • Alerce Investment Management fully exited Assembly Biosciences in Q4 2023, selling an estimated $1.97M.
  • Alerce Investment Management's ten largest holdings make up 100% of its $75.2M portfolio in Q4 2023.
  • Alerce Investment Management opened 0 new positions and closed 1 in Q4 2023.
  • Alerce Investment Management's portfolio value rose 28% quarter-over-quarter to $75.2M.

Based on Alerce Investment Management's 13F filing for Q4 2023, filed 9 Feb 2024.